Anti-agingMitochondrialEnergy

SS-31

What is SS-31?

SS-31 (Elamipretide) is a synthetic tetrapeptide that specifically targets mitochondria by binding to cardiolipin in the inner mitochondrial membrane. Stabilizes mitochondrial structure, preserves membrane integrity, enhances ATP production, and reduces free radical production. Improves ADP sensitivity in aged mitochondria, restores redox homeostasis, and protects neurons from dysfunction. Studied in clinical trials for mitochondrial myopathy, Barth syndrome, and heart failure. NOT FDA approved - investigational drug. Administered subcutaneously or IV in trials.

Benefits

  • Stabilizes Mitochondrial Membranes
  • Enhances ATP Production
  • Reduces Oxidative Stress
  • Neuroprotective Effects
  • Supports Cardiovascular Health
  • Improves Muscle Bioenergetics

Typical Dosage

  • Clinical trials: 40mg daily subcutaneous
  • Standard: 5-20mg daily subcutaneous
  • Starting: 5mg daily, increase to 10mg by week 3
  • Acute: 2mg daily for 2-4 days
  • Chronic: 2mg daily for 2-4 weeks
  • 8-12 week cycles

Side Effects

  • Generally well-tolerated in trials
  • Injection site reactions
  • Limited long-term human data

Negative Interactions

  • NOT FDA approved (investigational)
  • Research/clinical use only
HomeLibraryResearchFavoritesToolsVisuals